메뉴 건너뛰기




Volumn 22, Issue 12, 2009, Pages 1555-1563

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas

Author keywords

Adenocarcinoma; Chemotherapy; Classification; Esophagus; Regression

Indexed keywords

CISPLATIN;

EID: 71149100063     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.123     Document Type: Article
Times cited : (102)

References (27)
  • 1
    • 30944465690 scopus 로고    scopus 로고
    • Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment
    • DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006;13:12-30.
    • (2006) Ann Surg Oncol , vol.13 , pp. 12-30
    • DeMeester, S.R.1
  • 2
    • 33744732468 scopus 로고    scopus 로고
    • Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis
    • DOI 10.1158/1055-9965.EPI-05-0860
    • Kubo A, Corley DA. Body mass index and adenocarci-nomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomar-kers Prev 2006;15:872-878. (Pubitemid 43823511)
    • (2006) Cancer Epidemiology Biomarkers and Prevention , vol.15 , Issue.5 , pp. 872-878
    • Kubo, A.1    Corley, D.A.2
  • 4
    • 33745726677 scopus 로고    scopus 로고
    • Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    • Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
    • (2006) N Engl J Med , vol.355 , pp. 11-20
    • Cunningham, D.1    Allum, W.H.2    Stenning, S.P.3
  • 5
    • 34748814302 scopus 로고    scopus 로고
    • Induction chemotherapy in Barrett cancer: Influence on surgical risk and outcome
    • discussion 628-631
    • Siewert JR, Lordick F, Ott K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg 2007;246:624-628; discussion 628-631.
    • (2007) Ann Surg , vol.246 , pp. 624-628
    • Siewert, J.R.1    Lordick, F.2    Ott, K.3
  • 6
    • 35848968863 scopus 로고    scopus 로고
    • Final results of a randomized trial comparing preoperative 5-fluorour-acil (F)/cisplatin (P) to surgery alone in adenocarcino-ma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial
    • Boige V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorour-acil (F)/cisplatin (P) to surgery alone in adenocarcino-ma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol (Meeting Abstracts) 2007;25:4510.
    • (2007) J Clin Oncol (Meeting Abstracts) , vol.25 , pp. 4510
    • Boige, V.1    Pignon, J.2    Saint-Aubert, B.3
  • 7
    • 33847156303 scopus 로고    scopus 로고
    • Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
    • Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-234.
    • (2007) Lancet Oncol , vol.8 , pp. 226-234
    • Gebski, V.1    Burmeister, B.2    Smithers, B.M.3
  • 8
    • 40449133028 scopus 로고    scopus 로고
    • Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: Practical guidelines and current issues
    • Chang F, Deere H, Mahadeva U, et al. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am J Clin Pathol 2008;129:252-262.
    • (2008) Am J Clin Pathol , vol.129 , pp. 252-262
    • Chang, F.1    Deere, H.2    Mahadeva, U.3
  • 9
    • 0141515468 scopus 로고    scopus 로고
    • Tumor response to induction chemoradiation: Influence on survival after esophagectomy
    • discussion 636-637
    • Donington JS, Miller DL, Allen MS, et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg 2003;24:631-636; discussion 636-637.
    • (2003) Eur J Cardiothorac Surg , vol.24 , pp. 631-636
    • Donington, J.S.1    Miller, D.L.2    Allen, M.S.3
  • 10
    • 27144456518 scopus 로고    scopus 로고
    • Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma
    • Langer R, Specht K, Becker K, et al. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res 2005;11:7462-7469.
    • (2005) Clin Cancer Res , vol.11 , pp. 7462-7469
    • Langer, R.1    Specht, K.2    Becker, K.3
  • 11
    • 33751422222 scopus 로고    scopus 로고
    • The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging system
    • Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006;132:1374-1381.
    • (2006) J Thorac Cardiovasc Surg , vol.132 , pp. 1374-1381
    • Rizk, N.1    Venkatraman, E.2    Park, B.3
  • 12
    • 0141675069 scopus 로고    scopus 로고
    • Histomor-phology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
    • Becker K, Mueller JD, Schulmacher C, et al. Histomor-phology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003; 98:1521-1530.
    • (2003) Cancer , vol.98 , pp. 1521-1530
    • Becker, K.1    Mueller, J.D.2    Schulmacher, C.3
  • 13
    • 0031784518 scopus 로고    scopus 로고
    • Classification of adenocarcinoma of the oesophagogastric junction
    • Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85:1457-1459.
    • (1998) Br J Surg , vol.85 , pp. 1457-1459
    • Siewert, J.R.1    Stein, H.J.2
  • 14
    • 34548185461 scopus 로고    scopus 로고
    • PET to assess early metabolic response and to guide treatment of adeno-carcinoma of the oesophagogastric junction: The MU-NICON phase II trial
    • Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adeno-carcinoma of the oesophagogastric junction: the MU-NICON phase II trial. Lancet Oncol 2007;8:797-805.
    • (2007) Lancet Oncol , vol.8 , pp. 797-805
    • Lordick, F.1    Ott, K.2    Krause, B.J.3
  • 15
    • 47049120242 scopus 로고    scopus 로고
    • Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I) A comparison of two phase II trials with long-term follow-up
    • Bader FG, Lordick F, Fink U, et al. Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up. Onkologie 2008; 31:366-372.
    • (2008) Onkologie , vol.31 , pp. 366-372
    • Bader, F.G.1    Lordick, F.2    Fink, U.3
  • 16
    • 0035173618 scopus 로고    scopus 로고
    • A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemora-diotherapy
    • Dunne B, Reynolds JV, Mulligan E, et al. A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemora-diotherapy. J Clin Pathol 2001;54:841-845.
    • (2001) J Clin Pathol , vol.54 , pp. 841-845
    • Dunne, B.1    Reynolds, J.V.2    Mulligan, E.3
  • 17
    • 33646379877 scopus 로고    scopus 로고
    • The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
    • Brucher BL, Becker K, Lordick F, et al. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 2006;106: 2119-2127.
    • (2006) Cancer , vol.106 , pp. 2119-2127
    • Brucher, B.L.1    Becker, K.2    Lordick, F.3
  • 18
    • 38149082245 scopus 로고    scopus 로고
    • Histopathological response after preoperative radio-chemotherapy in rectal carcinoma is associated with improved overall survival
    • Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radio-chemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13.
    • (2008) J Surg Oncol , vol.97 , pp. 8-13
    • Rosenberg, R.1    Nekarda, H.2    Zimmermann, F.3
  • 19
    • 20144362218 scopus 로고    scopus 로고
    • Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemor-adiation
    • Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemor-adiation. Cancer 2005;103:1347-1355.
    • (2005) Cancer , vol.103 , pp. 1347-1355
    • Chirieac, L.R.1    Swisher, S.G.2    Ajani, J.A.3
  • 20
    • 20944447405 scopus 로고    scopus 로고
    • Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)
    • discussion 817-820
    • Swisher SG, Hofstetter W, Wu TT, et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 2005; 241:810-817; discussion 817-820.
    • (2005) Ann Surg , vol.241 , pp. 810-817
    • Swisher, S.G.1    Hofstetter, W.2    Wu, T.T.3
  • 21
    • 33845953627 scopus 로고    scopus 로고
    • Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor for patient outcome
    • Wu TT, Chirieac LR, Abraham SC, et al. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 2007;31:58-64.
    • (2007) Am J Surg Pathol , vol.31 , pp. 58-64
    • Wu, T.T.1    Chirieac, L.R.2    Abraham, S.C.3
  • 22
    • 0028305674 scopus 로고
    • Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma Clinico-pathologic correlations
    • Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinico-pathologic correlations. Cancer 1994;73:2680-2686.
    • (1994) Cancer , vol.73 , pp. 2680-2686
    • Mandard, A.M.1    Dalibard, F.2    Mandard, J.C.3
  • 23
    • 33947534209 scopus 로고    scopus 로고
    • American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multi-modality therapy for esophageal adenocarcinoma
    • Rizk NP, Venkatraman E, Bains MS, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multi-modality therapy for esophageal adenocarcinoma. J Clin Oncol 2007;25:507-512.
    • (2007) J Clin Oncol , vol.25 , pp. 507-512
    • Rizk, N.P.1    Venkatraman, E.2    Bains, M.S.3
  • 24
    • 27644561794 scopus 로고    scopus 로고
    • Histomor-phologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radioche-motherapy for esophageal cancer: Implications for response classification
    • Schneider PM, Baldus SE, Metzger R, et al. Histomor-phologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radioche-motherapy for esophageal cancer: implications for response classification. Ann Surg 2005;242:684-692.
    • (2005) Ann Surg , vol.242 , pp. 684-692
    • Schneider, P.M.1    Baldus, S.E.2    Metzger, R.3
  • 25
    • 22344446070 scopus 로고    scopus 로고
    • Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
    • Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005;23:4330-4337.
    • (2005) J Clin Oncol , vol.23 , pp. 4330-4337
    • Berger, A.C.1    Farma, J.2    Scott, W.J.3
  • 26
    • 0035886548 scopus 로고    scopus 로고
    • Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma
    • Brucher BL, Stein HJ, Werner M, et al. Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer 2001;92: 2228-2233.
    • (2001) Cancer , vol.92 , pp. 2228-2233
    • Brucher, B.L.1    Stein, H.J.2    Werner, M.3
  • 27
    • 14144254112 scopus 로고    scopus 로고
    • Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophago-gastric junction
    • von Rahden BH, Stein HJ, Feith M, et al. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophago-gastric junction. J Clin Oncol 2005;23:874-879.
    • (2005) J Clin Oncol , vol.23 , pp. 874-879
    • Von Rahden, B.H.1    Stein, H.J.2    Feith, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.